Influence of Upper Extremity Vibration on Spasticity and Function in Persons With Tetraplegia

July 15, 2019 updated by: Shepherd Center, Atlanta GA
Vibration therapy is a possible alternative to drug-based treatments for spasticity following SCI. Research indicates that it may provide temporary relief from spasticity, but many interventions under investigation are not portable and therefore access is limited. The aim of this study is to investigate the feasibility of using a portable vibrating device to decrease UE spasticity.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Georgia
      • Atlanta, Georgia, United States, 30309
        • Shepherd Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Have sustained cervical (neurological level C1-C8) SCI
  • Any ISNCSCI severity classification (A, B, C or D)
  • Have therapist-reported and self-reported spasticity in the arm or hand
  • Ability to pick up, move, and release at least one block (on the Box & Blocks Test)
  • May participate if utilizing prescription medications, including baclofen pump for control of spasticity

Exclusion Criteria:

  • Severe contractures of the arm/hand that limit passive movement of the elbow, wrist or fingers more than 50% of normal range of motion or presence of other orthopedic pathology that would adversely influence participation in the protocol
  • Any implanted catheter such as but not limited to CSF shunt, or the presence of pacemaker, implanted automatic internal cardioverter defibrillator (AICD, other cardiac implants and or conditions). Not including baclofen pump.
  • Severe pain or hypersensitivity of the arm/hand
  • Current pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Vibrating Ball
Vibrating ball is held in both hands. Participants complete 5 30-second bouts of 68 Hz vibration with a 1 minute rest in between each bout.
Parameters: 5 30-sec bouts of 68Hz vibration followed by a 1-minute rest.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Box and Blocks Test from pre-intervention to post intervention, from pre intervention to 20 minute follow up, from post intervention to 20 minute follow up
Time Frame: Day 1
Functional assessment of grasp and release
Day 1
Change in Modified Ashworth Scale from pre-intervention to post intervention, from pre intervention to 20 minute follow up, from post intervention to 20 minute follow up
Time Frame: Day 1
Clinical assessment of stretch-induced spasticity measured on a scale of 0-4 with 4 indicating the worst spasticity and 0 indicating no spasticity detectable upon clinical examination.
Day 1
Change in Global Impression of Change Scale from pre-intervention to post intervention, from pre intervention to 20 minute follow up, from post intervention to 20 minute follow up
Time Frame: Day 1
Self-report of improvement or deterioration over time measured on a scale of 1-7 with 1 indicating very much improved and 7 indicating very much worse
Day 1
Satisfaction and Adherence Questionnaire
Time Frame: 20 minute delay post intervention
Self- report of satisfaction with and perceived ability to adhere to the intervention
20 minute delay post intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hand strength
Time Frame: Pre-intervention, immediately post-intervention, 20 minute delay post intervention
Dynamometer measurement of grip strength
Pre-intervention, immediately post-intervention, 20 minute delay post intervention
Pinch strength
Time Frame: Pre-intervention, immediately post-intervention, 20 minute delay post intervention
Lateral pinch strength measured using a pinch meter
Pre-intervention, immediately post-intervention, 20 minute delay post intervention
Semmes-Weinstein Monofilament Test
Time Frame: Pre-intervention, immediately post-intervention, 20 minute delay post intervention
Assesment of light touch sensation
Pre-intervention, immediately post-intervention, 20 minute delay post intervention
Qualities of Spasticity Questionnaire
Time Frame: Baseline
Self-report of experience of spasticity
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 28, 2018

Primary Completion (ACTUAL)

February 20, 2019

Study Completion (ACTUAL)

February 20, 2019

Study Registration Dates

First Submitted

June 4, 2019

First Submitted That Met QC Criteria

July 15, 2019

First Posted (ACTUAL)

July 16, 2019

Study Record Updates

Last Update Posted (ACTUAL)

July 16, 2019

Last Update Submitted That Met QC Criteria

July 15, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on Vibrating ball

3
Subscribe